This editorial discusses the management of renin-angiotensin system inhibitors in patients experiencing declines in estimated glomerular filtration rate.
1Renal-Electrolyte and Hypertension Division, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania 2Department of Biostatistics, Epidemiology, and Informatics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania Correspondence: Dr. Jordana B. Cohen, email: email protected See related articles, "Association between Acute Declines in eGFR during Renin-Angiotensin System Inhibition and Risk of Adverse Outcomes," and "Estimated Effect of Restarting Renin-Angiotensin System Inhibitors after Discontinuation on Kidney Outcomes and Mortality," on pages XXX–XXX and XXX–XXX, respectively.
Shulman et al. (Tue,) conducted a editorial in Declines in eGFR. Renin-Angiotensin System Inhibitors was evaluated. This editorial discusses the management of renin-angiotensin system inhibitors in patients experiencing declines in estimated glomerular filtration rate.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: